《大行報告》高盛:國壽(02628.HK)去年盈利遜 投資收益疲弱
高盛發表報告指,中國人壽(02628.HK)去年淨利潤按年跌37%至321億元人民幣,遜於該行及市場預期;由於除稅後公允價值損失增加180億元人民幣,去年第四季的投資收益低於預期,令季內股東權益下降4%。該行予集團H股「買入」評級,目標價16元。
該行提到,雖然國壽淨利潤低於預期,但計劃派發每股0.49元人民幣的全年股息,大致符合預期,意味著派息率為43%,高於其約35%的歷史派息率。鑑於集團一直保持穩定的派息率,該行將關注國壽管理層會否有派息率結構性提升的計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.